135 related articles for article (PubMed ID: 13130390)
1. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761.
Hoerr R
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S56-61. PubMed ID: 13130390
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.
Gauthier S; Schlaefke S
Clin Interv Aging; 2014; 9():2065-77. PubMed ID: 25506211
[TBL] [Abstract][Full Text] [Related]
3. Strategies for the use of Ginkgo biloba extract, EGb 761
Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
[TBL] [Abstract][Full Text] [Related]
4. The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations.
Mercier C; Rollason V; Eshmawey M; Mendes A; Frisoni GB
Psychogeriatrics; 2024 Jul; 24(4):968-982. PubMed ID: 38638077
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials.
Tampi RR; Tampi DJ
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):565-74. PubMed ID: 25551131
[TBL] [Abstract][Full Text] [Related]
6. The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).
Peisah C; Strukovski JA; Wijeratne C; Mulholland R; Luscombe G; Brodaty H
Int Psychogeriatr; 2015 Aug; 27(8):1313-22. PubMed ID: 25642751
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Behavioural and Psychological Symptoms of Dementia in Individuals with Learning Disabilities.
Devshi R; Shaw S; Elliott-King J; Hogervorst E; Hiremath A; Velayudhan L; Kumar S; Baillon S; Bandelow S
Diagnostics (Basel); 2015 Dec; 5(4):564-76. PubMed ID: 26854171
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and psychological symptoms of dementia and mortality risk among people with cognitive impairment: an 8-year longitudinal study from the NCGG-STORIES.
Noguchi T; Nakagawa T; Sugimoto T; Komatsu A; Kuroda Y; Uchida K; Ono R; Arai H; Sakurai T; Saito T
J Epidemiol; 2024 Mar; ():. PubMed ID: 38522914
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations for the diagnostic and therapy of behavioural and psychological symptoms of dementia (BPSD)].
Savaskan E; Georgescu D; Becker S; Benkert B; Blessing A; Bürge M; Felbecker A; Hatzinger M; Hemmeter UM; Hirsbrunner T; Klöppel S; Latour Erlinger G; Lornsen FJ; Ngamsri T; Peter J; Schlögl M; Sollberger M; Verloo H; Vögeli S; Zúñiga F
Praxis (Bern 1994); 2024 Feb; 113(2):34-43. PubMed ID: 38536191
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with COVID-19 infection in patients with behavioural and psychological symptoms of dementia.
Fujii M; Butler JP; Sasaki H
Psychogeriatrics; 2024 May; 24(3):722-724. PubMed ID: 38494586
[No Abstract] [Full Text] [Related]
11. The biological basis of behavioral symptoms in dementia.
Garand L; Buckwalter KC; Hall GR
Issues Ment Health Nurs; 2000; 21(1):91-107. PubMed ID: 10839054
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia).
Giménez-Llort L; Johansson B
Front Pharmacol; 2021; 12():704421. PubMed ID: 34211400
[No Abstract] [Full Text] [Related]
13. Editorial: Behavior support for people with dementia.
Macfarlane S; Kurrle S; Grosvenor S; Cunningham C
Front Psychiatry; 2024; 15():1389668. PubMed ID: 38600986
[No Abstract] [Full Text] [Related]
14. VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders.
Gustafson DR; Kalaria R; O'Brien J; van den Brink H; Hilal S; Marseglia A; Ter Telgte A; Skoog I
Cereb Circ Cogn Behav; 2024; 6():100224. PubMed ID: 38868624
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
J Alzheimers Dis; 2015; 43(2):589-603. PubMed ID: 25114079
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S
J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264
[TBL] [Abstract][Full Text] [Related]
17. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
Bachinskaya N; Hoerr R; Ihl R
Neuropsychiatr Dis Treat; 2011; 7():209-15. PubMed ID: 21573082
[TBL] [Abstract][Full Text] [Related]
18. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
Napryeyenko O; Borzenko I;
Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
[TBL] [Abstract][Full Text] [Related]
19. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.
Scripnikov A; Khomenko A; Napryeyenko O;
Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
